Hacer Karataş

Hacer Karataş

İstanbul Medipol University - İstanbul / Türkiye
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 209633
İstanbul Medipol Üniversitesi
person_outline Hacer Karataş's MOST POPULAR ARTICLES
1-) Targeting MLL1 H3K4 methyltransferase activity in mixed-lineage leukemiaF Cao, EC Townsend, H Karatas, J Xu, L Li, S Lee, L Liu, Y Chen, ...Molecular cell 53 (2), 247-261, 20142842014
2-) In vivo molecular bioluminescence imaging: new tools and applicationsL Mezzanotte, M van‘t Root, H Karatas, EA Goun, CWGM LöwikTrends in biotechnology 35 (7), 640-652, 20172052017
3-) High-affinity, small-molecule peptidomimetic inhibitors of MLL1/WDR5 protein–protein interactionH Karatas, EC Townsend, F Cao, Y Chen, D Bernard, L Liu, M Lei, Y Dou, ...Journal of the American Chemical Society 135 (2), 669-682, 20131572013
4-) Structure-based design of high-affinity macrocyclic peptidomimetics to block the menin-mixed lineage leukemia 1 (MLL1) protein–protein interactionH Zhou, L Liu, J Huang, D Bernard, H Karatas, A Navarro, M Lei, S WangJournal of Medicinal Chemistry 56 (3), 1113-1123, 20131062013
5-) Discovery of a highly potent, cell-permeable macrocyclic peptidomimetic (MM-589) targeting the WD repeat domain 5 protein (WDR5)–mixed lineage leukemia (MLL) protein–protein …H Karatas, Y Li, L Liu, J Ji, S Lee, Y Chen, J Yang, L Huang, D Bernard, ...Journal of medicinal chemistry 60 (12), 4818-4839, 2017962017